Drawing for SYSTEMIC MEDICINE

USPTO serial 77011906

SYSTEMIC MEDICINE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SINGH, TEJBIR
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SYSTEMIC MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Antiallergic medicines; Central nervous system stimulants; Ginseng for medicinal use; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbs in dried or preserved form; Medicinal preparations for the mouth and as sprays; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal radix glycyrrhizae; Medicines for the treatment of gastrointestinal diseases; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Parapharmaceutical products for use in dermatology; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Processed cactus for medicinal or therapeutic purposesACTIVE—
035Development of hospital management systemsACTIVE—
042Basic and clinical research in the field of respiratory science and medicine; Product research and development; Research and development for new products for others; Research and development of vaccines and medicinesACTIVE—
044Health care in the nature of health maintenance organizations; Vitamin therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 1, 2007MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 1, 2007ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 26, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2007DOCKASSIGNED TO EXAMINER—
Feb 3, 2007AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Feb 3, 2007ALIEASSIGNED TO LIE—
Jan 10, 2007PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 5, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance